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\s=b\We investigated the relationship between risk factors for
cerebrovascular disease and cognitive function in 249
stroke-free community volunteers (age, 70.8\m=+-\6.7years;
education, 12.3\m=+-\4.6years) who were given tests of mem-
ory, language, visuospatial, abstract reasoning, and atten-
tional skills. Using logistic regression analyses, we examined
hypertension, diabetes mellitus, myocardial infarction, an-
gina, hypercholesterolemia, and cigarette smoking as po-
tential correlates of performance within these cognitive
domains. Controlling for demographic factors within the
logistic models, diabetes mellitus was a significant indepen-
dent correlate of abstract reasoning deficits (odds ratio,
10.9; 95% confidence interval, 2.2 to 54.9) and visuospa-
tial dysfunction (odds ratio, 3.5; confidence interval, 1.2 to
10.7), while hypercholesterolemia was a significant inde-
pendent correlate of memory dysfunction (odds ratio, 3.0;
confidence interval, 1.4 to 6.6). Prolonged exposure to vas-
cular risk factors such as diabetes mellitus and hypercho-
lesterolemia may lead to atherosclerotic disease, possibly
resulting in "silent" infarctions or impaired cerebral blood
flow and a decline in cognitive functioning.(Arcfi Neurol. 1993;50:162-166)
Risk factors for stroke have been extensively examinedand are well known; these include hypertension, di¬
abetes mellitus, cardiac disease, and smoking.1"3 Elevated
lipid levels have also been associated with stroke,4 and
small artery occlusion by cholesterol emboli has been
reported.5"7 Targeted interventions to modify risk factors,
especially hypertension, have proved effective in reducing
stroke risk.8 Cerebrovascular risk factors have also been
examined in healthy, asymptomatic subjects as determi¬
nants of cognitive function to identify the earliest neuro¬
logic consequences of risk factor exposure.9 If stroke-free
elderly subjects with vascular risk factors exhibit deficits in
intellectual performance, important public health implica¬
tions arise. Cognitive decline, possibly mediated through
the mechanism of clinically silent stroke, may be the first
sign of significant cerebrovascular disease.
Previous studies have suggested that certain risk factors
for cerebrovascular disease, including hypertension, dia¬
betes mellitus, cardiac disease, and hypercholesterolemia,
can affect performance on a variety of cognitive tasks.9
However, these studies have generally examined single
risk factors in small samples without controlling for a
broad range of potentially confounding exposures that
might also affect cognition. The purpose of our study was
to investigate the independent effects of cerebrovascular
risk factors on specific aspects of cognition while adjusting




As part of a longitudinal study of stroke and dementia,10 we
recruited 249 subjects (mean age, 70.8±6.7 years; mean education,
12.3±4.6 years) free of cerebrovascular disease by history or neu¬
rological examination. The majority of these subjects were ran¬
domly selected from Medicare records and a commercial list(53.0%), and the remainder of the cohort included volunteers from
the community (29.7%) and spouses of stroke patients (17.3%).
Procedures
Each subject received neurological, neuropsychological, and
functional examinations. Medical and risk factor histories were
collected through subject self-report by interview with a physi¬
cian. The primary risk factors considered in this study included
history of hypertension, diabetes mellitus, myocardial infarction,
angina, hypercholesterolemia, and consistent cigarette use (ie,
history of smoking at least one cigarette each day for a period of
at least 1 year). Other risk factors were not investigated due to lack
of association with stroke risk, rarity of exposure, or unacceptably
high levels of missing information. We also collected information
relevant to other potential correlates of cognitive function,
including demographic factors; medication use; consistent alco¬
hol use (ie, history of consumption of at least one serving of beer,
wine, or hard liquor each week for a period of at least 6 months);
and depression, assessed with the Hamilton Rating Scale for
Depression.11
Reliability and Validity of Medical History Information
The reliability and validity of the medical history self-reports
were evaluated. The medical history interview was readminis-
tered to 39 randomly selected members of the overall cohort. Each
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of the risk factors being investigated in this study had been en¬
dorsed by at least 10 members of this smaller sample, and 10 sub¬jects with no history of exposure to these risk factors were also
interviewed. Permission was sought from the subjects to contact
their personal physicians to validate their self-reports, with lab¬
oratory data being collected and used when available. Standard
values used in our institution served as criteria for diabetes mel¬
litus (ie, fasting glucose >7.7 mmol/L [&140 mg/dL]) and
hypercholesterolemia (ie, total cholesterol a6.20 mmol/L [a240
mg/dL]). Electrocardiographic results were used to diagnose
myocardial infarction. The diagnosis of hypertension required
multiple blood pressure measurements with elevated values (ie,
systolic blood pressure a 160 mm Hg or diastolic blood pressure
a 95 mm Hg) taken on separate days; the complexity of this
diagnosis and the extensive chart review that was required
necessitated our reliance on the physician's diagnosis in almost
all cases.
Neuropsychological Evaluation
Neuropsychological testing was performed in either English or
Spanish, based on the language spoken in the subject's home. The
test battery12 included measures of memory function (the Selec¬
tive Reminding Test and a multiple-choice recognition version of
the Benton Visual Retention Test), abstract reasoning skills (the
Similarities subtest of the Wechsler Adult Intelligence Scale-
Revised), verbal functions (selected items from the Boston Nam¬
ing Test and selected subtests from the Boston Diagnostic Apha¬
sia Examination), visuospatial functions (multiple-choice
matching version of the Benton Visual Retention Test and the
Rosen figure drawing test), and attentional skills (timed target-
finding task).
Statistical Analyses
Neuropsychology subtest scores were converted into  scores,
and the  scores for subtests within each cognitive domain were
averaged to represent overall performance within that domain.
Each subtest was equally weighted in these transformations. The
distribution of scores within each cognitive domain was divided
at the mean (ie, z=0) to form two groups, representing "better"
and "worse" performance. The mean was selected as the cutoff
because a more stringent criterion (eg, 2 SDs below the mean)
could mask potentially subtle risk factor effects. Subjects were
grouped based on the position of their scores in each of the dis¬
tributions and not on external criteria because no other normative
database exists for this battery of neuropsychological tests.
Logistic regression analyses were then performed to determine
the correlates of these performance-based groupings for each
cognitive domain. Logistic regression techniques were selected as
the primary analytic method rather than multiple linear regres¬
sion because the beta coefficient may be transformed into an odds
ratio (OR) for each independent variable, providing clearer infor¬
mation regarding the magnitude of risk factor effects. Following
the logistic analyses, however, we performed multiple regression
analyses to determine whether comparable results would be ob¬
tained if the dependent variables were treated as continuous,
rather than categorical, data. Independent variables for all anal¬
yses included vascular risk factors (ie, hypertension, diabetes
mellitus, myocardial infarction, angina, hypercholesterolemia,
and consistent cigarette use), demographic variables (ie, age, ed¬
ucation, race, sex, and occupation), medications used (ie, phar¬
macologie treatment for hypertension, diabetes, cardiac disease,
and hyperlipidemia), total score on the Hamilton Depression
Rating Scale, and consistent alcohol use. Demographic variables
were forced into each of the final equations, with age and educa¬
tion being entered as continuous data and race, sex, and occupa¬
tion being entered as categorical data.
RESULTS
Descriptive statistics and frequencies of vascular risk
factor exposure and medication use are presented in Table
Table 1.—Descriptive Statistics and Frequencies
of Risk Factor Exposure and Medication Use
Variable  % of Cohort
Demographic
Sex, male 85 34.1
Race, white 130 52.2
Risk factors
Hypertension 105 42.2
Diabetes mellitus 29 11.6
Myocardial infarction 19 7.7
Angina 34 13.7
Hypercholesterolemia 62 25.2
Consistent alcohol use 127 51.0
Consistent cigarette use 121 48.6
Medication treatment
Hypertension 84 33.7
Diabetes mellitus 18 7.2
Cardiac disease 53 21.3
Hyperlipidemia 13 5.2
1. Women outnumbered men in this elderly cohort; this is
consistent with population trends related to the greater life
expectancy of women.13 The most frequently acknowl¬
edged risk factor was hypertension, followed by hyper¬
cholesterolemia, cardiac disease, and diabetes mellitus.
The results of the reliability and validity analyses of the
medical history self-reports are presented in Table 2. Re¬
liability coefficients (ie, ks) were highest for self-reports
regarding diabetes mellitus, myocardial infarction, and
angina, while positive predictive value was highest for
hypercholesterolemia, myocardial infarction, and angina.
Vascular Risk Factors as Correlates of Cognitive Function
The results of the logistic regression analyses are dis¬
cussed with regard to each cognitive domain.
Memory Functions.—Significant correlates of memory
dysfunction included older age (OR, 1.1; 95% confidence
interval [CI], 1.0 to 1.2), lower education (OR, 1.2; CI, 1.1
to 1.4), nonwhite race (OR, 2.7; CI, 1.3 to 5.5), male sex (OR,
4.9; CI, 2.2 to 10.7), and nonprofessional occupation (OR,
2.7; CI, 1.2 to 6.4). Controlling for these factors within the
multivariate model, hypercholesterolemia (OR, 3.0; CI, 1.4
to 6.6) was a significant independent correlate of memory
dysfunction.
Descriptive statistics and neuropsychological test results
broken down by history of hypercholesterolemia are pre¬
sented in Table 3.
Abstract Reasoning.—Lower education (OR, 1.4; CI, 1.2
to 1.6) and nonwhite race (OR, 7.4; CI, 3.5 to 15.8) were
significant correlates of abstract reasoning deficits. Age,
sex, and occupation were forced into the final model. Con¬
trolling for these factors within the multivariate model,
diabetes mellitus (OR, 10.9; CI, 2.2 to 54.9) was a significant
independent correlate of abstract reasoning deficits.
Descriptive statistics and neuropsychological test results
broken down by history of diabetes mellitus are also
shown in Table 3.
Verbal Functions.—Lower education (OR, 1.2; CI, 1.1 to
1.3), male sex (OR, 3.2; CI, 1.6 to 6.6), and nonwhite race(OR, 3.1; CI, 1.6 to 6.3) were significant correlates of verbal
dysfunction. Age and occupation were forced into the fi¬
nal model. None of the vascular risk factors were signifi¬
cantly related to performance in this cognitive domain.
Visuospatial Functions.—Lower education (OR, 1.2; CI,
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Table 2.—Reliability and Validity of Risk Factor History*




























'Results are based on data collected from a randomly selected subgroup of 39 subjects.
Table 3.—Descriptive Statistics and Test Results by History of Hypercholesterolemia and Diabetes Mellitus*
Hypercholesterolemia Diabetes Mellitus
I I I I
Yes No Yes No
Variable (n=62) (n=187) (n=29) (n=220)
Age 71.6±6.8 70.6±6.6 69.8±6.3 71.0±6.8
Education 13.2±4.5 12.0±4.5 10.2 + 5.1 12.6±4.4
Memory -0.03i0.81 0.02 + 0.87 -0.23i0.82 0.03+0.86
Abstraction 0.23+0.81 -0.08i0.87 -0.57 + 0.91 0.07+0.82
Verbal 0.11 ±0.77 -0.03±0.73 -0.24±0.63 0.03+0.76
Visuospatial 0.16±0.85 -0.06i0.84 -0.35±0.63 0.05i0.86
Attention 0.09+0.63 -0.03i0.72 -0.05±0.47 0.01 iO.72
HDRS 3.8+4.4 3.4±3.8 3.5 + 3.9 3.5+4.0
*Results presented for each cognitive domain are  scores based on the performance of the full cohort. Values are expressed as means+SDs. HDRS
indicates Hamilton Depression Rating Scale.
1.1 to 1.3), nonwhite race (OR, 4.6; CI, 2.3 to 9.1), and non-
professional occupation (OR, 2.3; CI, 1.0 to 5.0) were sig¬
nificant correlates of visuospatial dysfunction. Age and sex
were forced into the final model. Controlling for these fac¬
tors within the multivariate model, diabetes mellitus (OR,
3.5; CI, 1.2 to 10.7) was a significant independent correlate
of visuospatial dysfunction.
Attentional Functions.—Lower education (OR, 1.2; CI,
1.1 to 1.3) and male sex (OR, 2.2; CI, 1.2 to 4.3) were sig¬
nificant correlates of attentional deficits. Age, race, and
occupation were forced into the final equation. None of the
vascular risk factors were significantly related to perfor¬
mance in this cognitive domain.
The results of the multiple regression analyses were
comparable with those of the logistic regression analyses,
with hypercholesterolemia being a significant indepen¬
dent correlate of memory dysfunction (ß=
—
.14) and dia¬
betes mellitus being a significant independent correlate of
abstract reasoning deficits (ß= —.11). A significant relation¬
ship was not found between diabetes mellitus and visu¬
ospatial dysfunction, however. As noted in the logistic
analyses, none of the vascular risk factors were signifi¬
cantly related to performance in the verbal or attentional
domains.
COMMENT
Specific risk factors for cerebrovascular disease were as¬
sociated with cognitive dysfunction in our stroke-free eld¬
erly cohort. Logistic regression analyses determined that
diabetes mellitus was strongly related to abstract reason¬
ing deficits and visuospatial dysfunction, while hypercho¬
lesterolemia was strongly related to memory dysfunction.
Multiple linear regression analyses supported all of these
findings except the relationship between diabetes mellitus
and visuospatial dysfunction; thus, this finding should be
considered tentative. These significant relationships were
independent of other variables that may influence cogni¬
tive function, such as demographic factors. In addition,
medication use, a history of consistent alcohol use, and to¬
tal score on the Hamilton Rating Scale for Depression were
not significantly related to performance within any of the
cognitive domains.
The frequency of exposure to vascular risk factors in our
cohort was consistent with prevalence rates reported in the
general population.14 Although we did not measure vas¬
cular risks directly, subject self-reports of medical and risk
factor history were both reliable, with coefficients showing
good to excellent agreement beyond chance,15 and valid,
with high positive predictive value and good to excellent
sensitivity and specificity. The reliability of self-reported
risk factor history has been examined in another study in
the same community using a random sample of 145 sub¬jects.16 Reliability coefficients for self-reported history of
hypertension ( , .69), diabetes mellitus ( , .60), and cho¬
lesterol level ( , .60) were all significant (P<.001), repre¬
senting good agreement beyond chance. In our sample,
disagreement between patient's self-report of hypercho¬
lesterolemia and physician's records occurred in nine of 39
cases. In eight of those nine cases the disagreements
resulted from false-negative reports by the patient. To the
extent that underenumeration of exposure status might
have occurred in the cohort overall, the relationship
between hypercholesterolemia and memory function
should be even more robust.
Patients with diabetes mellitus may exhibit deficits in
general neuropsychological performance17 as well as in
specific areas of cognition, such as memory.18 Althoughdepression may contribute to some of the cognitive deficits
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exhibited by diabetics,19·20 the degree of cognitive impair¬
ment appears to be related, more importantly, to glycémie
control,21 with significant cognitive deficits in acute hy¬
poglycemia22 and milder deficits in hyperglycémie states.23
In addition, patients with more severe diabetes, defined as
a longer duration of illness, greater incidence of complica¬
tions, or increased frequency of hypoglycémie episodes,
exhibit greater cognitive deficits.24
Several studies have suggested that hypercholester¬
olemia and hypertriglyceridemia are associated with im¬
paired cognitive function. Better performance in mental
status testing may be related to higher levels of high-
density lipoprotein cholesterol,25 and a form of dementia
due to extremely high levels of plasma lipids has been re¬ported.26 Lowering of the total serum cholesterol level may
improve cognitive performance.27 Similarly, elevated tri¬
glycéride levels have been associated with deficits in cod¬
ing, attention, and reaction time testing.28 Treatment withgemfibrozil, resulting in a reduced triglycéride but not to¬
tal cholesterol level, has led to improvement in mental
status.29
Patients with ischemie heart disease tend to be more
cognitively impaired than those with nonischemic disease,
particularly in the areas of memory and concentration.30
Prospective cardiac transplantation patients exhibit defi¬
cits in multiple cognitive domains,30 while patients with
valvular heart disease may have memory impairment.31
Hypertension has been associated with deficits in gen¬
eral intellectual performance,32 memory function,33 visu¬
ospatial function,34 and performance in simple34 and
choice35 reaction time testing. In contrast to these signifi¬
cant findings in small cohorts of hypertensive subjects, we
found no relationship between hypertension and cogni¬
tion. Similarly, the Framingham study found only a weak
relationship between "definite hypertension" and imme¬
diate verbal memory and attention in 2032 elderly stroke-
free subjects. After adjusting for multiple comparisons, this
finding was not significant. No relationship was obtained
between any cognitive function and systolic or diastolic
blood pressure, borderline hypertension, or the use of an¬
tihypertensive medications.36
One possible explanation for our findings is clinically
"silent" infarction resulting from exposure to risk factors.Elevated levels of plasma lipids and diabetes mellitus have
been associated with microcirculatory disturbances; mi-
croangiopathy, sometimes resulting in lacunar infarction;
and, in extreme cases, "subcortical arteriosclerotic enceph¬
alopathy."37 In an imaging study of 246 neurologically
normal adults, silent lacunar infarctions were noted in
13%, with male sex, older age, history of hypertension,
mean arterial blood pressure, and retinal artery sclerosis
significantly related to the lesions.38 In the Framingham
cohort, glucose intolerance was the only significant corre¬
late of imaged but clinically silent lesions in patients with
first stroke.39 In other imaging studies of subjects with40
and without41 symptoms of cerebrovascular disease, a sig¬
nificant relationship has been noted between number of
risk factors and number of "silent" or incidental infarc¬
tions, but the role of individual risk factors in producing
such lesions was not investigated.
Vascular risk factors also may have transient effects on
cognitive function by producing disorders of cerebralblood flow. Reductions in cerebral perfusion have been
observed in combination with elevated cholesterol and
triglycéride levels, either due to large-vessel atherosclero-
sis42 or impaired vasomotor reactivity with increased
small-vessel resistance.43 Diabetes mellitus also affects ce¬
rebral blood flow and may produce disorders of autoreg-
ulation and reactivity.44 The increased blood viscosity ofdiabetics45 may contribute to reduced cerebral blood
flow.46 Increased viscosity is also seen in patients with an¬
gina, possibly due to an elevated hematocrit,47 providing
another basis for reduced flow.46-48 Cerebral blood flow also
has been found to be reduced in patients with clinically si¬lent infarctions.38
Although we documented adequate reliability and va¬
lidity of subject self-reports regarding medical history, fu¬
ture studies should measure these factors directly. For ex¬
ample, plasma glucose level at the time of examination is
related to cognitive performance.21 A similar relationship
may apply to cholesterol, or its components. Should such
dynamic relationships be demonstrated, it would suggest
that metabolic factors or cerebral blood flow alterations
affect cognition, rather than "silent" infarction. The most
direct way to address these issues would be to examine
clinically stroke-free subjects with brain imaging and cere¬bral blood flow studies along with neuropsychological
testing.
The results of this study demonstrate an independent
relationship between specific risk factors and cognition in
individuals free of stroke. These findings support more
aggressive management of vascular risk factors in stroke-
free populations, not only to reduce the incidence of stroke,
but also to prevent subtle cognitive dysfunction that may
result from the effects of those risk factors.
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